THERAPY AREA
Oncology & Immunology
Molecules in this area
Abiraterone
Cytochrome P450 17A1 Inhibitor
Abiraterone Acetate
Cytochrome P450 17A1 Inhibitor
Acalabrutinib
Bruton's tyrosine kinase (BTK) inhibitors
Adagrasib
Other antineoplastic agents
Adalimumab
Tumor necrosis factor alpha (TNF-alpha) inhibitors
Adalimumab-Adbm
Tumor necrosis factor alpha (TNF-alpha) inhibitors
Adalimumab-Afzb
Tumor necrosis factor alpha (TNF-alpha) inhibitors
Adalimumab-Atto
Tumor Necrosis Factor Blocker
Adalimumab-Ryvk
Tumor necrosis factor alpha (TNF-alpha) inhibitors
Aflibercept
Other antineoplastic agents
Alectinib Hydrochloride
Anaplastic lymphoma kinase (ALK) inhibitors
Alpelisib
Phosphatidylinositol-3-kinase (Pi3K) inhibitors
Aminolevulinic Acid Hydrochloride
Optical Imaging Agent
Anagrelide Hydrochloride
Platelet-reducing Agent
Anakinra
Interleukin inhibitors
Anastrozole
Aromatase inhibitors
Apalutamide
Anti-androgens
Arsenic Trioxide
Other antineoplastic agents
Asciminib
BCR-ABL tyrosine kinase inhibitors
Atezolizumab
PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
AUBAGIO
Dihydroorotate dehydrogenase (DHODH) inhibitors
Avacopan
Complement inhibitors
Avapritinib
Kinase Inhibitor
Axatilimab
Monoclonal antibodies
Axatilimab-Csfr
Colony Stimulating Factor-1 Receptor Blocker
Axitinib
Kinase Inhibitor
Azacitidine
Nucleoside Metabolic Inhibitor
Azathioprine
Purine Antimetabolite
Basiliximab
Interleukin-2 Receptor Blocking Antibody
Belatacept
Selective T Cell Costimulation Blocker
Belimumab
B Lymphocyte Stimulator-specific Inhibitor
Belumosudil
Selective immunosuppressants
Bendamustine Hydrochloride
Alkylating Drug
Bevacizumab
VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors
Bexarotene
Retinoid
Bicalutamide
Androgen Receptor Inhibitor
Bleomycin
Cytoprotective Agent
Bortezomib
Proteasome Inhibitor
Bosutinib
Kinase Inhibitor
Brigatinib
Kinase Inhibitor
Brodalumab
Interleukin inhibitors
Cabazitaxel
Taxanes
Cabozantinib
Other protein kinase inhibitors
Calaspargase Pegol
Other antineoplastic agents
Capecitabine
Nucleoside Metabolic Inhibitor
Capivasertib
Other protein kinase inhibitors
Capmatinib
Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors
Carboplatin
Platinum-based Drug
Carfilzomib
Proteasome inhibitors
Carmustine
Nitrosoureas
Celecoxib
Nonsteroidal Anti-inflammatory Drug
Cemiplimab
PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors